About Krankenhaus Bethanien
Das Krankenhaus Bethanien Moers ist eine im nordrhein-westfälischen Moers am westlichen Rand des Ruhrgebietes ansässige Klinik. Träger ist die Stiftung Krankenhaus Bethanien für die Grafschaft Moers. Das Krankenhaus verfügt über 510 Betten und beschäftigt rund 1800 Mitarbeiter.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
ResMed
3
Janssen Research & Development, LLC
2
Amgen
1
Heinrich-Heine University, Duesseldorf
1
Radboud University Medical Center
1
Clinical Trials at Krankenhaus Bethanien
During the past decade, Krankenhaus Bethanien conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy With or Without Darbepoetin Alfa in Treating Women With Stage III Breast Cancer
2004-01-01
Unknown status
1,234
Treatment of Predominant Central Sleep Apnoea by Adaptive Servo Ventilation in Patients With Heart Failure
2008-02-01
2015-06-01
Completed
1,325
Substudy on the Mechanistic Plausibility of the Clinical Benefits of Adaptive Servo-ventilation
2012-08-01
2015-06-01
Completed
312
Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry
2007-11-01
2013-05-01
Completed
6,876
Blood Pressure After PREeclampsia/HELLP by SELF Monitoring Study
2017-07-13
2019-12-30
Completed
200
Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200).
2020-06-04
2026-04-27
Active, not recruiting
345
A Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared With Carboplatin-Pemetrexed, in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Characterized by Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions
2020-10-13
2025-01-31
Active, not recruiting
308
A Study of Amivantamab and Lazertinib in Combination With Platinum-Based Chemotherapy Compared With Platinum-Based Chemotherapy in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non- Small Cell Lung Cancer After Osimertinib Failure
2021-11-17
2026-12-29
Recruiting
690
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Krankenhaus Bethanien" #1 sponsor was "ResMed" with 3 trials, followed by "Janssen Research & Development, LLC" with 2 trials
sponsored, "Amgen" with 1 trials sponsored, "Heinrich-Heine University, Duesseldorf" with 1 trials sponsored and "Radboud University Medical Center"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Krankenhaus Bethanien"
#1 collaborator was "CRI-The Clinical Research Institute GmbH" with 1 trials as a collaborator and "INTERREG V-A" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Krankenhaus Bethanien
According to Clinical.Site data, the most researched conditions in "Krankenhaus Bethanien" are
"Carcinoma, Non-Small-Cell Lung" (2 trials), "Heart Failure" (2 trials), "Breast Cancer" (1 trials), "Cardiovascular Diseases" (1 trials) and "Cardiovascular Risk Factor" (1 trials). Many other conditions were trialed in "Krankenhaus Bethanien" in a lesser frequency.
Clinical Trials Intervention Types at Krankenhaus Bethanien
Most popular intervention types in "Krankenhaus Bethanien" are "Drug" (4 trials), "Device" (3 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Amivantamab" (2 trials), "Carboplatin" (2 trials), "Pemetrexed" (2 trials), "AMG 510" (1 trials) and "Docetaxel" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Krankenhaus Bethanien
The vast majority of trials in "Krankenhaus Bethanien" are
6 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Krankenhaus Bethanien
Currently, there are NaN active trials in "Krankenhaus Bethanien".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Krankenhaus Bethanien,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Krankenhaus Bethanien, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 3 trials that are defined as “Not Applicable".